$KMFG
KEEMO Fashion Group Ltd

2023 Q4 Form 10-Q Financial Statement

#000149315223044638 Filed on December 13, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2022 Q4
Revenue $6.516K
YoY Change
Cost Of Revenue $3.405K
YoY Change
Gross Profit $3.111K
YoY Change
Gross Profit Margin 47.74%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit -$25.87K -$4.945K
YoY Change 423.09%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$25.87K -$4.945K
YoY Change 423.09%
Income Tax
% Of Pretax Income
Net Earnings -$25.87K -$4.945K
YoY Change 423.09%
Net Earnings / Revenue -396.98%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 5.500M shares 3.600M shares
Diluted Shares Outstanding 5.500M shares 3.600M shares

Balance Sheet

Concept 2023 Q4 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $4.054K $14.00K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $5.000K
Prepaid Expenses $2.809K
Receivables $6.516K
Other Receivables
Total Short-Term Assets $18.38K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $18.38K
Total Long-Term Assets $0.00
Total Assets $18.38K $16.29K
YoY Change 12.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $50.92K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $50.92K
Total Long-Term Liabilities
Total Liabilities $50.92K
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$64.64K
YoY Change
Common Stock $5.500K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$32.54K -$17.92K
YoY Change
Total Liabilities & Shareholders Equity $18.38K
YoY Change

Cashflow Statement

Concept 2023 Q4 2022 Q4
OPERATING ACTIVITIES
Net Income -$25.87K -$4.945K
YoY Change 423.09%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$24.69K -$4.083K
YoY Change 504.68%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities -$24.69K -$4.083K
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash -$24.69K -$4.083K
YoY Change 504.68%
FREE CASH FLOW
Cash From Operating Activities -$24.69K -$4.083K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 dei Amendment Flag
AmendmentFlag
false
CY2023Q4 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q4 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--07-31
CY2023Q4 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q4 dei Entity Central Index Key
EntityCentralIndexKey
0001935033
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2022Q4 us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2022Q4 us-gaap Gross Profit
GrossProfit
usd
CY2023Q4 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
usd
CY2022Q4 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
usd
CY2023Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
usd
CY2022Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
usd
CY2022Q4 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
usd
CY2023Q4 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
usd
CY2022Q4 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
usd
CY2023Q4 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022Q4 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2023Q4 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2022Q4 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2023Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2022Q4 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
pure
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
usd
CY2023Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
usd
CY2022Q4 us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2022Q4 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
pure
CY2023Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
usd
CY2022Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
usd
CY2023Q4 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2023Q4 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2023Q4 KFGL Capital Expenditure
CapitalExpenditure
usd
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2022Q4 us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2022Q4 KFGL Capital Expenditure
CapitalExpenditure
usd
CY2023Q4 KFGL Capital Expenditure
CapitalExpenditure
usd
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2022Q4 us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2022Q4 KFGL Capital Expenditure
CapitalExpenditure
usd
CY2023Q4 dei Document Type
DocumentType
10-Q
CY2023Q4 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q4 dei Document Period End Date
DocumentPeriodEndDate
2023-10-31
CY2023Q4 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q4 dei Entity File Number
EntityFileNumber
333-267967
CY2023Q4 dei Entity Registrant Name
EntityRegistrantName
KEEMO FASHION GROUP LIMITED
CY2023Q4 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023Q4 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
32-0686375
CY2023Q4 dei Entity Address Address Line1
EntityAddressAddressLine1
69 Wanke Boyu
CY2023Q4 dei Entity Address Address Line2
EntityAddressAddressLine2
Xili Liuxin 1st Rd
CY2023Q4 dei Entity Address Address Line3
EntityAddressAddressLine3
Nanshan District
CY2023Q4 dei Entity Address City Or Town
EntityAddressCityOrTown
Shenzhen
CY2023Q4 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
518052
CY2023Q4 dei Entity Address Country
EntityAddressCountry
CN
CY2023Q4 dei City Area Code
CityAreaCode
+86
CY2023Q4 dei Local Phone Number
LocalPhoneNumber
176-1282-2030
CY2023Q4 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q4 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q4 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q4 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q4 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023Q4 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023Q4 dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5500000 shares
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4054 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28743 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6516 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6954 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
5000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
3405 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2809 usd
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
3933 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
18379 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
43035 usd
CY2023Q4 us-gaap Assets
Assets
18379 usd
CY2023Q3 us-gaap Assets
Assets
43035 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3200 usd
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
9300 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
50916 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
49705 usd
CY2023Q4 us-gaap Liabilities
Liabilities
50916 usd
CY2023Q3 us-gaap Liabilities
Liabilities
49705 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5500000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5500000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5500000 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5500000 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
5500 usd
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
5500 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
26600 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
26600 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-64637 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-38770 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-32537 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-6670 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
18379 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
43035 usd
CY2023Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6516 usd
CY2023Q4 us-gaap Cost Of Revenue
CostOfRevenue
3405 usd
CY2023Q4 us-gaap Gross Profit
GrossProfit
3111 usd
CY2023Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
28978 usd
CY2022Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4945 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-25867 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-4945 usd
CY2023Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-25867 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4945 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-25867 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-4945 usd
CY2023Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-25867 usd
CY2022Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4945 usd
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5500000 shares
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5500000 shares
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3600000 shares
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3600000 shares
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-6670 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-25867 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-32537 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-12974 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-12974 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-4945 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-17919 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-17919 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-25867 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-4945 usd
CY2023Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-438 usd
CY2023Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1595 usd
CY2022Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-212 usd
CY2023Q4 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-1124 usd
CY2023Q4 us-gaap Increase Decrease In Due To Other Related Parties
IncreaseDecreaseInDueToOtherRelatedParties
7311 usd
CY2022Q4 us-gaap Increase Decrease In Due To Other Related Parties
IncreaseDecreaseInDueToOtherRelatedParties
1200 usd
CY2023Q4 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-6100 usd
CY2022Q4 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-550 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-24689 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4083 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-24689 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4083 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28743 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18080 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4054 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13997 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-25867 usd
CY2023Q4 KFGL Working Capital
WorkingCapital
32537 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-32537 usd
CY2023Q4 us-gaap Operating Loss Carryforwards Limitations On Use
OperatingLossCarryforwardsLimitationsOnUse
The NOL carryforwards begin to expire in 2043
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
17195 usd
CY2023Q4 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_847_eus-gaap--UseOfEstimates_zo2Ae0ICGXge" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_868_zHuu3Y3brt76">Use of Estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management uses estimates and assumptions in preparing these financial statements in accordance with US GAAP. Those estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities in the balance sheets, and the reported revenue and expenses during the periods reported. Actual results may differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35 pure
CY2023Q4 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
5000 usd
CY2023Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
3405 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
5000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
3405 usd
CY2023Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
2809 usd
CY2023Q3 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
3933 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2809 usd
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
3933 usd
CY2023Q4 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
64637 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3200 usd
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
9300 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3200 usd
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
9300 usd
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5500000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5500000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5500000 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5500000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2023Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-25867 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-4945 usd
CY2023Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-25867 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4945 usd
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35 pure
CY2023Q4 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35 pure
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
17195 usd
CY2023Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
8142 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
17195 usd
CY2023Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6516 usd
CY2023Q4 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1 pure
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6516 usd
CY2023Q4 us-gaap Cost Of Revenue
CostOfRevenue
3405 usd
CY2023Q4 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1 pure
CY2023Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6516 usd
CY2023Q4 us-gaap Cost Of Revenue
CostOfRevenue
3405 usd
CY2023Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
28978 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-25867 usd
CY2023Q4 us-gaap Assets
Assets
18379 usd
CY2022Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4945 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-4945 usd
CY2022Q4 us-gaap Assets
Assets
16289 usd
CY2023Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6516 usd
CY2023Q4 us-gaap Cost Of Revenue
CostOfRevenue
3405 usd
CY2023Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
28978 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-25867 usd
CY2023Q4 us-gaap Assets
Assets
18379 usd
CY2022Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4945 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-4945 usd
CY2022Q4 us-gaap Assets
Assets
16289 usd

Files In Submission

Name View Source Status
0001493152-23-044638-index-headers.html Edgar Link pending
0001493152-23-044638-index.html Edgar Link pending
0001493152-23-044638.txt Edgar Link pending
0001493152-23-044638-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
kfgl-20231031.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
kfgl-20231031_def.xml Edgar Link unprocessable
kfgl-20231031_lab.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
kfgl-20231031_cal.xml Edgar Link unprocessable
kfgl-20231031_pre.xml Edgar Link unprocessable